Sign In
Buy DMTK
$0.0940
+0 (+0%)
At Close: Oct 21, 2024
Buying These 3 Stocks Could Make You Rich Over the Next Decade
06:08am, Friday, 13'th Nov 2020
Great things appear to be in store for these rising stars.
DermTech, Inc. (DMTK) CEO John Dobak on Q3 Results - Earnings Call Transcript
08:07pm, Tuesday, 10'th Nov 2020
DermTech, Inc. (DMTK) CEO John Dobak on Q3 Results - Earnings Call Transcript
3 Healthcare Stocks to Watch
06:38pm, Monday, 26'th Oct 2020
Discover how these three companies could change the face of healthcare.
DermTech (DMTK) & Its Competitors Head to Head Contrast
07:58am, Tuesday, 13'th Oct 2020
DermTech (NASDAQ: DMTK) is one of 37 publicly-traded companies in the “Medical laboratories” industry, but how does it compare to its rivals? We will compare DermTech to similar businesses based o
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
DermTech, Inc. Reports Second Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Wednesday, 05'th Aug 2020
DermTech, Inc. Reports Second Quarter 2020 Financial Results and Provides Corporate Update
DermTech Announces Inclusion in the Russell 2000 Index
12:00pm, Tuesday, 30'th Jun 2020
DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that as part of the annual reconstitution of the Russell
Here's Why We're Not Too Worried About DermTech's (NASDAQ:DMTK) Cash Burn Situation
10:40am, Tuesday, 16'th Jun 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Here is What Hedge Funds Think About DermTech, Inc. (DMTK)
07:27pm, Wednesday, 10'th Jun 2020
In this article you are going to find out whether hedge funds think DermTech, Inc. (NASDAQ:DMTK) is a good investment right now. We like to check what the smart money thinks first before doing extensi
DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the DermTech Pigmented Lesion Assay (the "DermTech
DermTech, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Wednesday, 13'th May 2020
DermTech, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update
DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that SKIN, the official journal of the National Society
The Melanoma Research Foundation Hosting Weekly Facebook Live ‘Ask a Dermatologist’ Sessions throughout Melanoma Awareness Month
01:15pm, Tuesday, 05'th May 2020
DermTech, Inc. (NASDAQ:DMTK) ("DermTech") and the Melanoma Research Foundation (MRF) recognize Melanoma Awareness Month this May with an "Ask a Dermatologist" webinar series offered on MRF’s Faceboo
DermTech Announces Telemedicine Solution to Enable Remote Use of its Non-Invasive Adhesive Patch Test for Melanoma Detection
08:41pm, Thursday, 30'th Apr 2020
DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), today announced that its lead non-invasive melanoma detection test, the DermTech Pigmented Lesion Assay (the "DermTech PLA"), is now available for use by cl
DermTech Announces Response to COVID-19
12:00pm, Wednesday, 25'th Mar 2020
DermTech Announces Response to COVID-19
